65 related articles for article (PubMed ID: 19951577)
1. Tumor suppressor cylindromatosis: expressed in IgA nephropathy and negatively associated with renal tubulo-interstitial lesion.
Sun F; Zheng X; E J; Liu G; Wang ZG; Cui TG
Chin Med J (Engl); 2009 Nov; 122(21):2603-7. PubMed ID: 19951577
[TBL] [Abstract][Full Text] [Related]
2. An emerging role of deubiquitinating enzyme cylindromatosis (CYLD) in the tubulointerstitial inflammation of IgA nephropathy.
Cui TG; Ichikawa T; Yang M; Dong X; Li J; Cui T
Biochem Biophys Res Commun; 2009 Dec; 390(2):307-12. PubMed ID: 19800320
[TBL] [Abstract][Full Text] [Related]
3. Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy.
Tomioka M; Hiromura K; Sakairi T; Takeuchi S; Maeshima A; Kaneko Y; Kuroiwa T; Takeuchi T; Nojima Y
Nephrology (Carlton); 2010 Aug; 15(5):568-74. PubMed ID: 20649878
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
Rong ZH; Wang C; Hao J; Duan HJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):275-8. PubMed ID: 18471357
[TBL] [Abstract][Full Text] [Related]
5. Histomorphometric correlates of renal failure in IgA nephropathy.
Vleming LJ; de Fijter JW; Westendorp RG; Daha MR; Bruijn JA; van Es LA
Clin Nephrol; 1998 Jun; 49(6):337-44. PubMed ID: 9696428
[TBL] [Abstract][Full Text] [Related]
6. Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsy.
Widstam-Attorps U; Berg U; Bohman SO; Lefvert AK
Clin Nephrol; 1992 Nov; 38(5):245-53. PubMed ID: 1451337
[TBL] [Abstract][Full Text] [Related]
7. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[TBL] [Abstract][Full Text] [Related]
8. Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies.
Drakopoulos A; Goumenos DS; Vlachojannis JG; Tsakas S
Ren Fail; 2006; 28(6):461-7. PubMed ID: 16928614
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte infiltration and intercellular adhesion molecule-1-mediated cell interactions in immunoglobulin A nephropathy.
Arrizabalaga P; Solé M; Quintó L; Ascaso C; Engel P
Arch Pathol Lab Med; 1998 Sep; 122(9):817-22. PubMed ID: 9740142
[TBL] [Abstract][Full Text] [Related]
10. [Relationship of mitogen-activated protein kinases activation with transdifferentiation of renal tubular epithelial cells in patients with IgA nephropathy].
Zhang M; Li XM
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):898-903. PubMed ID: 15329273
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
Kennoki T; Ishida H; Yamaguchi Y; Tanabe K
Transplantation; 2009 Oct; 88(7):935-41. PubMed ID: 19935466
[TBL] [Abstract][Full Text] [Related]
13. The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy.
Ranieri E; Gesualdo L; Grandaliano G; Maiorano E; Schena FP
J Nephrol; 2001; 14(4):253-62. PubMed ID: 11506247
[TBL] [Abstract][Full Text] [Related]
14. Loss of CYLD might be associated with development of salivary gland tumors.
Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
[TBL] [Abstract][Full Text] [Related]
15. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
16. CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study.
Wagrowska-Danilewicz M; Danilewicz M; Stasikowska O
Pol J Pathol; 2005; 56(3):121-6. PubMed ID: 16334979
[TBL] [Abstract][Full Text] [Related]
17. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
[TBL] [Abstract][Full Text] [Related]
18. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
19. Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria.
Shimotomai T; Kakei M; Narita T; Koshimura J; Hosoba M; Kato M; Komatsuda A; Ito S
Ren Fail; 2005; 27(3):323-8. PubMed ID: 15957550
[TBL] [Abstract][Full Text] [Related]
20. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
